|
ORMP Oramed Pharmaceuticals, Inc. 1176309 |
| Balance Sheet |
|
Current Assets
|
$68,150,000.00 |
|
Assets
|
$268,847,000.00 |
|
Current Liabilities
|
$10,563,000.00 |
|
Equity
|
$199,744,000.00 |
|
Shares Out
|
40926081.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,915,000.00 |
|
Investing Cash Flow
|
$-19,488,000.00 |
| Market Analysis |
Market Cap
|
$168,615,453.72 |
|
Price
|
$4.14 |
|
BVPS
|
4.88 |
|
PB
|
0.84 |
|
EPS
|
0.94 |
|
PE
|
1.80 |
|
PS
|
94.13 |
|
FCF
|
$-2,920,000.00 |
|
| Dividends |
|
Dividend Increment
|
Annual |
|
Dividend Amount
|
0.25 |
|
Dividend Yield |
6.14% |
|
Dividend Data Last Updated
|
2026-08-01 09:31:36 |
|
| Jan |
Feb |
Mar |
| Ex: 2026-01-16 |
Pay: 2026-01-26 |
|
|
|
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
1.50 |
|
|
2026-05-19 |
0.91 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
0.31 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
1.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ORMP documents filed with the SEC.
ORMP Filings
Clear
